Consensus Freenome, Inc.

Stocks

FRNM

US35661P1003

Biotechnology & Medical Research

End-of-day quote Nasdaq 20/10/2026			5-day change	1st Jan Change
14.06 ^USD	+11.85%		+19.66%	+7.90%

20/10	Freenome, Inc. Launches SimpleScreenTM Lung And Personalized Cancer Detection Offering With SimpleScreen CRC	CI
20/10	Freenome Launches SimpleScreen Lung Cancer Test	MT

Evolution of the Average Target: Freenome, Inc.

Evolution of the Average Target - Freenome, Inc.

Evolution of the Target Price: Freenome, Inc.

Evolution of the Target Price - Freenome, Inc.

Changes in Analyst Recommendations: Freenome, Inc.

7803b66c66f37b3df247b6c9c.eDcR8lYF8pNFyjHNOMdBipwSMSnx4e8FWMBf_ZK7RsM.HllUuj5mw9ocuXa_UPYexNhVU2i7zLZKK48avuePDqE7fHuWHFS12wCoZA~5e4610369ac798efc8900449a19080f6

Analysts' recommendations: Freenome, Inc.

20/08	Guggenheim Initiates Freenome at Buy With $21 Price Target	MT
18/08	TD Cowen Initiates Freenome at Buy With $17 Price Target	MT
18/08	Freenome Shares Rise After Jefferies Initiates Coverage	MT
17/08	Jefferies Initiates Freenome at Buy, With $17 Price Target	MT
17/08	BTIG Initiates Freenome at Buy, With $17 Price Target	MT
17/08	Jefferies Initiates Freenome at Hold, With $17 Price Target	MT
14/08	Leerink Partners Capital Initiates Freenome With Outperform Rating, With $18 Price Target	MT

More recommendations

Bio Diagnostics & Testing

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	FREENOME, INC.					+40.96%
	WUXI APPTEC CO., LTD.					+32.59%
	ARGENX SE					+28.07%
	LONZA GROUP AG					+10.26%
	IQVIA HOLDINGS INC.					+8.34%
	BEONE MEDICINES AG					+15.58%
	REVOLUTION MEDICINES, INC.					+38.43%
	CELLTRION, INC.					+38.53%
	WUXI BIOLOGICS (CAYMAN) INC.					+31.23%
	GENMAB A/S					+4.99%
	Average					+24.90%
	Weighted average by Cap.					+23.41%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

5

Last Close Price

12.77USD

Average target price

18.00USD

Spread / Average Target

+40.96%

High Price Target

21.00USD

Spread / Highest target

+64.45%

Low Price Target

17.00USD

Spread / Lowest Target

+33.12%

Analyst Consensus Detail

Analyst consensus - Freenome, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Freenome, Inc.

Stock Market
Stocks
FRNM Stock
Consensus Freenome, Inc.

As early as today, start finding the best investment opportunities!